Company / Current Assets per Share
Lilly (Eli) Current Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$61.58
FY2025
5-year range
$19.72 / $61.58
FY2021-FY2025
Trend
+70.2%
vs FY2024
Sector context
#8 of 210
Health Care
What the data says
Among 210 Health Care companies, Lilly (Eli) is in the top 4% for current assets per share. Current Assets per Share has increased for 6 consecutive years, from $13.03 in FY2019 to $61.58 in FY2025.
Based on SEC 10-K filings.
61.58 in FY2025 with a 5-year CAGR of +29.5%. Top quartile in the Health Care sector.
Improved from $28.22 to $61.58 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +46.1%
- 5-Year CAGR
- +29.5%
- 10-Year CAGR
- -
Sector benchmark
-54.2% below sector average
Key checks
Key Insights
- Lilly (Eli)'s current assets per share has grown for 6 consecutive years.
- In FY2025, current assets per share increased 70.2% year-over-year.
- Ranks #8 out of 210 companies in the Health Care sector.
- Lowest current assets per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 1.02 (distress zone, below 1.8 threshold)
- Strong profit margin: 31.0%
- Low earnings quality (accrual-heavy earnings)
- Strong return on equity: 77.4%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $61.58 | +70.2% |
| FY2024 | $36.19 | +28.3% |
| FY2023 | $28.22 | +42.8% |
| FY2022 | $19.76 | +0.2% |
| FY2021 | $19.72 | +16.7% |
| FY2020 | $16.89 | +29.6% |
| FY2019 | $13.03 | -32.7% |
| FY2018 | $19.35 | +7.4% |
| FY2017 | $18.02 | +28.2% |
| FY2016 | $14.06 | +21.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026